single-cell analysis
Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing
Fluidigm tallied $39.9 million in revenues compared to $26.5 million a year ago, and well above analysts' consensus estimate of $32.5 million.
BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
Bio-Rad Q1 Revenues Rise 3 Percent
Bio-Rad said it is withdrawing its previously issued annual revenue guidance given the uncertainties regarding the duration and impact of the COVID-19 pandemic.
Celsee, Kindstar Ink Chinese Distribution Deal for Single-Cell Isolation Platform
Kindstar has also agreed to purchase Genesis systems for use by its scientists to monitor circulating tumor cells and for single-cell research.
Researchers at Baylor College of Medicine and Columbia University found that almost all blood samples from pregnant women tested contained several trophoblasts.